{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:04:29Z","timestamp":1786489469494,"version":"build-2736575974"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-025-00527-y","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T05:12:58Z","timestamp":1768021978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hereditary renal cell carcinoma surveillance protocols: a review of the literature and proposed recommendations"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5179-4491","authenticated-orcid":false,"given":"Miguel","family":"Miranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Berta","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Palma dos Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tito","family":"Palmela Leit\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"527_CR1","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1200\/JCO.2013.50.8192","volume":"32","author":"B Shuch","year":"2014","unstructured":"Shuch B, Vourganti S, Ricketts CJ, Middleton L, Peterson J, Merino MJ et al (2014) Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol 32:431\u2013437","journal-title":"J Clin Oncol"},{"key":"527_CR2","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/MOU.0b013e32832f0d40","volume":"19","author":"JA Coleman","year":"2009","unstructured":"Coleman JA, Russo P (2009) Hereditary and Familial kidney cancer. Curr Opin Urol 19:478\u2013485","journal-title":"Curr Opin Urol"},{"key":"527_CR3","unstructured":"Ljungberg B, Albiges L, Bedke J A. Bex (Vice-chair), U. Capitanio, R. H. Giles (Patient Advocate), M. Hora, T. Klatte L. Marconi, T. Powles, A. Volpe Guidelines Associates: Y. Abu-Ghanem, R. Campi, S. Dabestani, S. Fern\u00e1ndez-Pello Montes, F. Hofmann, T. Kuusk, R. Tahbaz Guidelines Office: N. Schouten, E-J. Smith. EAU Guidelines on Renal Cell Carcinoma, European Association of Urology; n.d"},{"key":"527_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/PAP.0b013e318299b7c6","volume":"20","author":"CG Przybycin","year":"2013","unstructured":"Przybycin CG, Magi-Galluzzi C, McKenney JK (2013) Hereditary syndromes with associated renal neoplasia: a practical guide to histologic recognition in renal tumor resection specimens. Adv Anat Pathol 20:245\u2013263","journal-title":"Adv Anat Pathol"},{"key":"527_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1053\/j.semdp.2018.01.005","volume":"35","author":"H Moch","year":"2018","unstructured":"Moch H, Ohashi R, Gandhi JS, Amin MB (2018) Morphological clues to the appropriate recognition of hereditary renal neoplasms. Semin Diagn Pathol 35:184\u2013192","journal-title":"Semin Diagn Pathol"},{"key":"527_CR6","unstructured":"Cancer Stat Facts Kidney and Renal Pelvis Cancer. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: 2022. https:\/\/seer.cancer.gov\/statfacts\/html\/kidrp.html (Accessed 2016\u20132020)"},{"key":"527_CR7","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","volume":"361","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM et al (2003) Von Hippel-Lindau disease. Lancet 361:2059\u20132067","journal-title":"Lancet"},{"key":"527_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.rcl.2015.12.004","volume":"54","author":"KP Shanbhogue","year":"2016","unstructured":"Shanbhogue KP, Hoch M, Fatterpaker G, Chandarana H (2016) Von Hippel-Lindau disease: review of genetics and imaging. Radiol Clin North Am 54:409\u2013422","journal-title":"Radiol Clin North Am"},{"key":"527_CR9","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2214\/AJR.14.13514","volume":"204","author":"S Gupta","year":"2015","unstructured":"Gupta S, Kang HC, Ganeshan DM, Bathala TK, Kundra V (2015) Diagnostic approach to hereditary renal cell carcinoma. AJR Am J Roentgenol 204:1031\u20131041","journal-title":"AJR Am J Roentgenol"},{"key":"527_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ejhg.2010.175","volume":"19","author":"ER Maher","year":"2011","unstructured":"Maher ER, Neumann HP, Richard S (2011) Von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet 19:617\u2013623","journal-title":"Eur J Hum Genet"},{"key":"527_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ejhg.2016.173","volume":"25","author":"MLM Binderup","year":"2017","unstructured":"Binderup MLM, Galanakis M, Budtz-J\u00f8rgensen E, Kosteljanetz M, Luise Bisgaard M (2017) Prevalence, birth incidence, and penetrance of von Hippel-Lindau disease (vHL) in Denmark. Eur J Hum Genet 25:301\u2013307","journal-title":"Eur J Hum Genet"},{"key":"527_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/jmg.33.2.120","volume":"33","author":"IR Maddock","year":"1996","unstructured":"Maddock IR, Moran, Maher ER, Teare MD, Norman, Payne SJ (1996) A genetic register von Hippel-Lindau disease. J Med Genet 33:120\u2013127","journal-title":"J Med Genet"},{"key":"527_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.5489\/cuaj.1496","volume":"7","author":"MN Reaume","year":"2013","unstructured":"Reaume MN, Graham GE, Tomiak E, Kamel-Reid S, Jewett MAS, Bjarnason GA et al (2013) Canadian guideline on genetic screening for hereditary renal cell cancers. Can Urol Assoc J 7:319\u2013323","journal-title":"Can Urol Assoc J"},{"key":"527_CR14","volume-title":"Health professional Version. PDQ cancer information summaries","author":"PDQ Cancer Genetics Editorial Board","year":"2024","unstructured":"PDQ Cancer Genetics Editorial Board (2024) Genetics of Renal Cell Carcinoma (PDQ\u00ae). Health professional Version. PDQ cancer information summaries. National Cancer Institute (US), Bethesda (MD)"},{"key":"527_CR15","unstructured":"Mikhail MI, Singh AK (2023) Von Hippel-Lindau syndrome. StatPearls"},{"key":"527_CR16","unstructured":"van Leeuwaarde RS, Ahmad S, van Nesselrooij B, Zandee W, Giles RH (2000) In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, GeneReviews\u00ae et al (eds) Von Hippel-Lindau syndrome. University of Washington, Seattle, Seattle (WA)"},{"key":"527_CR17","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1136\/jmedgenet-2021-108216","volume":"59","author":"K Zhang","year":"2022","unstructured":"Zhang K, Qiu J, Yang W, Ma K, Li L, Xie H et al (2022) Clinical characteristics and risk factors for survival in affected offspring of von Hippel-Lindau disease patients. J Med Genet 59:951\u2013956","journal-title":"J Med Genet"},{"key":"527_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejrad.2018.01.026","volume":"101","author":"M Czarniecki","year":"2018","unstructured":"Czarniecki M, Gautam R, Choyke PL, Turkbey B (2018) Imaging findings of hereditary renal tumors, a review of what the radiologist should know. Eur J Radiol 101:8\u201316","journal-title":"Eur J Radiol"},{"key":"527_CR19","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2214\/ajr.159.6.1442389","volume":"159","author":"PL Choyke","year":"1992","unstructured":"Choyke PL, Glenn GM, Walther MM, Zbar B, Weiss GH, Alexander RB, Hayes WS, Long JP, Thakore KN, Linehan WM (1992) The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients. AJR Am J Roentgenol 159:1229\u20131234","journal-title":"AJR Am J Roentgenol"},{"key":"527_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1148\/radiology.194.3.7862955","volume":"194","author":"PL Choyke","year":"1993","unstructured":"Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B (1993) Von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 194:629\u2013642","journal-title":"Radiology"},{"key":"527_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10689-011-9503-5","volume":"11","author":"J Zhang","year":"2012","unstructured":"Zhang J, Pan J-H, Dong B-J, Xue W, Liu D-M, Huang Y-R (2012) Active surveillance of renal masses in von Hippel-Lindau disease: growth rates and clinical outcome over a median follow-up period of 56 months. Fam Cancer 11:209\u2013214","journal-title":"Fam Cancer"},{"key":"527_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000333348","volume":"88","author":"CA Jilg","year":"2012","unstructured":"Jilg CA, Neumann HP, Gl\u00e4sker S, Sch\u00e4fer O, Ardelt PU, Schwardt M et al (2012) Growth kinetics in von Hippel-Lindau-associated renal cell carcinoma. Urol Int 88:71\u201378","journal-title":"Urol Int"},{"key":"527_CR23","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1200\/JCO.19.02263","volume":"38","author":"MW Ball","year":"2020","unstructured":"Ball MW, An JY, Gomella PT, Gautam R, Ricketts CJ, Vocke CD et al (2020) Growth rates of genetically defined renal tumors: implications for active surveillance and intervention. J Clin Oncol 38:1146\u20131153","journal-title":"J Clin Oncol"},{"key":"527_CR24","unstructured":"Alliance VHL (2017) VHLA Suggested Active Surveillance Guidelines 2020"},{"key":"527_CR25","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1007\/s00345-020-03441-3","volume":"39","author":"J Chahoud","year":"2021","unstructured":"Chahoud J, McGettigan M, Parikh N, Boris RS, Iliopoulos O, Rathmell WK et al (2021) Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease. World J Urol 39:2409\u20132415","journal-title":"World J Urol"},{"key":"527_CR26","doi-asserted-by":"publisher","first-page":"104538","DOI":"10.1016\/j.ejmg.2022.104538","volume":"65","author":"M Louise","year":"2022","unstructured":"Louise M, Binderup M, Smerdel M, Borgwadt L, Beck Nielsen SS, Madsen MG, M\u00f8ller HU et al (2022) Von Hippel-Lindau disease: updated guideline for diagnosis and surveillance. Eur J Med Genet 65:104538","journal-title":"Eur J Med Genet"},{"key":"527_CR27","unstructured":"Stichting Opsporing Erfelijke Tumoren en Vereniging Klinische Genetica Nederland, W.K.O (2017) Erfelijke en Familiaire Tumoren Richtlijnen Voor Diagnostiek en Preventie n.d"},{"key":"527_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1399-0004.2009.01281.x","volume":"77","author":"ML Poulsen","year":"2010","unstructured":"Poulsen ML, Budtz-Jorgensen E, Bisgaard ML (2010) Surveillance von Hippel- Lindau disease (vHL). Clin Genet 77:49\u201359","journal-title":"Clin Genet"},{"key":"527_CR29","unstructured":"Motzer RJ, Gunn A, Michaelson MD, Jonasch E, Haas N, Agarwal N et al NCCN clinical practice guidelines in oncology (NCCN guidelines\u00ae) kidney cancer 2025"},{"key":"527_CR30","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1002\/cncr.34896","volume":"129","author":"AB Daniels","year":"2023","unstructured":"Daniels AB, Tirosh A, Huntoon K, Mehta GU, Spiess PE, Friedman DL et al (2023) Guidelines for surveillance of patients with von Hippel-Lindau disease: consensus statement of the international VHL surveillance guidelines consortium and VHL alliance. Cancer 129:2927\u20132940","journal-title":"Cancer"},{"key":"527_CR31","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1158\/1078-0432.CCR-24-3525","volume":"31","author":"SP Rednam","year":"2025","unstructured":"Rednam SP, Becktell KD, Villani A, Brodeur GM, States LJ, Doria AS et al (2025) Update on surveillance in von Hippel-Lindau disease. Clin Cancer Res 31:2271\u20132277","journal-title":"Clin Cancer Res"},{"key":"527_CR32","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1002\/cncr.34265","volume":"128","author":"WPG Wolters","year":"2022","unstructured":"Wolters WPG, Dreijerink KMA, Giles RH, van der Horst-Schrivers ANA, van Nesselrooij B, Zandee WT et al (2022) Multidisciplinary integrated care pathway for von Hippel-Lindau disease. Cancer 128:2871\u20132879","journal-title":"Cancer"},{"key":"527_CR33","unstructured":"Predir (2023) R\u00e9seau National de R\u00e9f\u00e9rence pour Cancers Rares de l\u2019Adulte. Recommandations nationales VHL 2018"},{"key":"527_CR34","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1158\/1078-0432.CCR-17-0547","volume":"23","author":"SP Rednam","year":"2017","unstructured":"Rednam SP, Erez A, Druker H, Janeway KA, Kamihara J, Kohlmann WK et al (2017) Von Hippel\u2013Lindau and hereditary Pheochromocytoma\/Paraganglioma syndromes: clinical Features, Genetics, and surveillance recommendations in childhood. Clin Cancer Res 23:e68\u201375","journal-title":"Clin Cancer Res"},{"key":"527_CR35","doi-asserted-by":"publisher","first-page":"E214","DOI":"10.5489\/cuaj.3798","volume":"10","author":"J-B Lattouf","year":"2016","unstructured":"Lattouf J-B, Pautler SE, Reaume MN, Kim RH, Care M, Green J et al (2016) Structured assessment and followup for patients with hereditary kidney tumour syndromes. Can Urol Assoc J 10:E214\u2013E222","journal-title":"Can Urol Assoc J"},{"key":"527_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1530\/ERC-13-0308","volume":"21","author":"RC Kruizinga","year":"2014","unstructured":"Kruizinga RC, Sluiter WJ, De Vries E (2014) Calculating opti- Mal surveillance detection von Hippel-Lindau-related man- ifestations. Endocr Relat Cancer 21:63\u201371","journal-title":"Endocr Relat Cancer"},{"key":"527_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11934-018-0829-5","volume":"19","author":"Y Freifeld","year":"2018","unstructured":"Freifeld Y, Ananthakrishnan L, Margulis V (2018) Imaging for screening and surveillance of patients with hereditary forms of renal cell carcinoma. Curr Urol Rep 19:82","journal-title":"Curr Urol Rep"},{"key":"527_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.15586\/jkcvhl.2017.88","volume":"4","author":"N Varshney","year":"2017","unstructured":"Varshney N, Kebede AA, Owusu-Dapaah H, Lather J, Kaushik M, Bhullar JS (2017) A review of von Hippel-Lindau syndrome. J Kidney Cancer VHL 4:20\u201329","journal-title":"J Kidney Cancer VHL"},{"key":"527_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/j.sult.2016.10.002","volume":"38","author":"S Gaur","year":"2017","unstructured":"Gaur S, Turkbey B, Choyke P (2017) Hereditary renal tumor syndromes: update on diagnosis and management. Semin Ultrasound CT MR 38:59\u201371","journal-title":"Semin Ultrasound CT MR"},{"key":"527_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ejhg.2013.180","volume":"22","author":"J Decker","year":"2014","unstructured":"Decker J, Neuhaus C, Macdonald F, Brauch H, Maher ER (2014) Clinical utility gene card: von Hippel-Lindau (VHL). Eur J Hum Genet 22:1\u20134","journal-title":"Eur J Hum Genet"},{"key":"527_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000345668","volume":"41","author":"A Chou","year":"2013","unstructured":"Chou A, Toon C, Pickett J, Gill AJ (2013) Von Hippel-Lindau syndrome. Front Horm Res 41:30\u201349","journal-title":"Front Horm Res"},{"key":"527_CR42","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.2214\/AJR.12.9079","volume":"199","author":"BE Northrup","year":"2012","unstructured":"Northrup BE, Jokerst CE, Grubb RL 3rd, Menias CO, Khanna G, Siegel CL (2012) Hereditary renal tumor syndromes: imaging findings and management strategies. AJR Am J Roentgenol 199:1294\u20131304","journal-title":"AJR Am J Roentgenol"},{"key":"527_CR43","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1097\/01.cad.0000390768.93282.65","volume":"22","author":"J Garc\u00edas-Donas","year":"2011","unstructured":"Garc\u00edas-Donas J, Hernando S, Romero N, Jara C (2011) Knowledge hereditary renal cancer syndromes: pending issue oncologists. Anticancer Drugs 22:S15\u201320","journal-title":"Anticancer Drugs"},{"key":"527_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1148\/rg.281075052","volume":"28","author":"RS Leung","year":"2008","unstructured":"Leung RS, Biswas SV, Duncan M, Rankin S (2008) Imaging features of von Hippel-Lindau disease. Radiographics 28:65\u201379 quiz 323","journal-title":"Radiographics"},{"key":"527_CR45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2265.2000.00956.x","volume":"52","author":"LB Johnston","year":"2000","unstructured":"Johnston LB, Chew SL, Trainer PJ, Reznek R, Grossman AB, Besser GM et al (2000) Screening children at risk of developing inherited endocrine neoplasia syndromes. Clin Endocrinol (Oxf) 52:127\u2013136","journal-title":"Clin Endocrinol (Oxf)"},{"key":"527_CR46","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/ng0597-68","volume":"16","author":"L Schmidt","year":"1997","unstructured":"Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P et al (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16:68\u201373","journal-title":"Nat Genet"},{"key":"527_CR47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13000-021-01170-8","volume":"16","author":"S Ferlicot","year":"2021","unstructured":"Ferlicot S, Just P-A, Comp\u00e9rat E, Rouleau E, Tissier F, Vaessen C et al (2021) Clear cell and papillary renal cell carcinomas in hereditary papillary renal cell carcinoma (HPRCC) syndrome: a case report. Diagn Pathol 16:107","journal-title":"Diagn Pathol"},{"key":"527_CR48","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1002\/cncr.24230","volume":"115","author":"WM Linehan","year":"2009","unstructured":"Linehan WM, Pinto PA, Bratslavsky G, Pfaffenroth E, Merino M, Vocke CD et al (2009) Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer 115:2252\u20132261","journal-title":"Cancer"},{"key":"527_CR49","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/01.ju.0000139583.63354.e0","volume":"172","author":"LS Schmidt","year":"2004","unstructured":"Schmidt LS, Nickerson ML, Angeloni D, Glenn GM, Walther MM, Albert PS et al (2004) Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the Met proto-oncogene. J Urol 172:1256\u20131261","journal-title":"J Urol"},{"key":"527_CR50","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.eururo.2010.08.031","volume":"58","author":"J Verine","year":"2010","unstructured":"Verine J, Pluvinage A, Bousquet G, Lehmann-Che J, de Bazelaire C, Soufir N et al (2010) Hereditary renal cancer syndromes: an update of a systematic review. Eur Urol 58:701\u2013710","journal-title":"Eur Urol"},{"key":"527_CR51","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/00004728-199709000-00014","volume":"21","author":"PL Choyke","year":"1997","unstructured":"Choyke PL, Walther MM, Glenn GM, Wagner JR, Venzon DJ, Lubensky IA et al (1997) Imaging features of hereditary papillary renal cancers. J Comput Assist Tomogr 21:737\u2013741","journal-title":"J Comput Assist Tomogr"},{"key":"527_CR52","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.purol.2013.08.323","volume":"23","author":"C Maurin","year":"2013","unstructured":"Maurin C (2013) Tumeurs r\u00e9nales des maladies h\u00e9r\u00e9ditaires. Prog Urol 23:1157\u20131162","journal-title":"Prog Urol"},{"key":"527_CR53","unstructured":"HLRCC Family Alliance (2013) HLRCC handbook"},{"key":"527_CR54","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ng849","volume":"30","author":"IPM Tomlinson","year":"2002","unstructured":"Tomlinson IPM, Alam NA, Rowan AJ, Barclay E, Jaeger EEM, Kelsell D et al (2002) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406\u2013410","journal-title":"Nat Genet"},{"key":"527_CR55","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10689-009-9306-0","volume":"9","author":"I Alrashdi","year":"2010","unstructured":"Alrashdi I, Levine S, Paterson J, Saxena R, Patel SR, Depani S et al (2010) Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patient. Fam Cancer 9:239\u2013243","journal-title":"Fam Cancer"},{"key":"527_CR56","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10689-018-0076-4","volume":"17","author":"PT Bhola","year":"2018","unstructured":"Bhola PT, Gilpin C, Smith A, Graham GE (2018) A retrospective review of 48 individuals, including 12 families, molecularly diagnosed with hereditary leiomyomatosis and renal cell cancer (HLRCC). Fam Cancer 17:615\u2013620","journal-title":"Fam Cancer"},{"key":"527_CR57","volume-title":"FH tumor predisposition syndrome. GeneReviews(\u00ae)","author":"J Kamihara","year":"1993","unstructured":"Kamihara J, Schultz KA, Rana HQ (1993) FH tumor predisposition syndrome. GeneReviews(\u00ae). University of Washington, Seattle, Seattle (WA)"},{"key":"527_CR58","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.humpath.2022.08.006","volume":"136","author":"SK Mohanty","year":"2023","unstructured":"Mohanty SK, Lobo A, Cheng L (2023) The 2022 revision of the world health organization classification of tumors of the urinary system and male genital organs: advances and challenges. Hum Pathol 136:123\u2013143","journal-title":"Hum Pathol"},{"key":"527_CR59","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1016\/j.juro.2007.01.155","volume":"177","author":"RL Grubb","year":"2007","unstructured":"Grubb RL, Franks ME, Toro J, Middelton L, Choyke L, Fowler S et al (2007) Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol 177:2074\u20132079 discussion 2079\u201380","journal-title":"J Urol"},{"key":"527_CR60","doi-asserted-by":"publisher","first-page":"284","DOI":"10.5114\/pjp.2017.73920","volume":"68","author":"N Kuroda","year":"2017","unstructured":"Kuroda N, Ohe C, Kato I, Furuya M, Baba M, Nagashima Y et al (2017) Review of hereditary leiomyomatosis renal cell carcinoma with focus on clinical and Pathobiological aspects of renal tumors. Pol J Pathol 68:284\u2013290","journal-title":"Pol J Pathol"},{"key":"527_CR61","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10689-014-9735-2","volume":"13","author":"FH Menko","year":"2014","unstructured":"Menko FH, Maher ER, Schmidt LS, Middelton LA, Aittom\u00e4ki K, Tomlinson I et al (2014) Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. Fam Cancer 13:637\u2013644","journal-title":"Fam Cancer"},{"key":"527_CR62","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2147\/IJNRD.S42097","volume":"7","author":"LS Schmidt","year":"2014","unstructured":"Schmidt LS, Linehan WM (2014) Hereditary leiomyomatosis and renal cell carcinoma. Int J Nephrol Renovasc Dis 7:253\u2013260","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"527_CR63","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1158\/1078-0432.CCR-17-0629","volume":"23","author":"KAP Schultz","year":"2017","unstructured":"Schultz KAP, Rednam SP, Kamihara J, Doros L, Achatz MI, Wasserman JD et al (2017) PTEN, DICER1, FH, and their associated tumor susceptibility syndromes: clinical features, genetics, and surveillance recommendations in childhood. Clin Cancer Res 23:e76\u201382","journal-title":"Clin Cancer Res"},{"key":"527_CR64","doi-asserted-by":"publisher","first-page":"324","DOI":"10.5489\/cuaj.1685","volume":"7","author":"WM Linehan","year":"2013","unstructured":"Linehan WM (2013) Evaluation and screening for hereditary renal cell cancers. Can Urol Assoc J 7:324\u2013325","journal-title":"Can Urol Assoc J"},{"key":"527_CR65","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10689-011-9491-5","volume":"11","author":"KY van Spaendonck-Zwarts","year":"2012","unstructured":"van Spaendonck-Zwarts KY, Badeloe S, Oosting SF, Hovenga S, Semmelink HJF, van Moorselaar RJA et al (2012) Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance. Fam Cancer 11:123\u2013129","journal-title":"Fam Cancer"},{"key":"527_CR66","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1399-0004.2010.01486.x","volume":"79","author":"DL Smit","year":"2011","unstructured":"Smit DL, Mensenkamp AR, Badeloe S, Breuning MH, Simon MEH, van Spaendonck KY et al (2011) Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. Clin Genet 79:49\u201359","journal-title":"Clin Genet"},{"key":"527_CR67","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10689-011-9428-z","volume":"10","author":"HJ Lehtonen","year":"2011","unstructured":"Lehtonen HJ (2011) Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Fam Cancer 10:397\u2013411","journal-title":"Fam Cancer"},{"key":"527_CR68","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","volume":"2","author":"ML Nickerson","year":"2002","unstructured":"Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML et al (2002) Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dub\u00e9 syndrome. Cancer Cell 2:157\u2013164","journal-title":"Cancer Cell"},{"key":"527_CR69","doi-asserted-by":"publisher","first-page":"667311","DOI":"10.3389\/fcell.2021.667311","volume":"9","author":"JMJ Ramirez Reyes","year":"2021","unstructured":"Ramirez Reyes JMJ, Cuesta R, Pause A, Folliculin (2021) A regulator of transcription through AMPK and mTOR signaling pathways. Front Cell Dev Biol 9:667311","journal-title":"Front Cell Dev Biol"},{"key":"527_CR70","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/modpathol.3800152","volume":"17","author":"MB Warren","year":"2004","unstructured":"Warren MB, Torres-Cabala CA, Turner ML, Merino MJ, Matrosova VY, Nickerson ML et al (2004) Expression of Birt\u2013Hogg\u2013Dub\u00e9 gene mRNA in normal and neoplastic human tissues. Mod Pathol 17:998\u20131011","journal-title":"Mod Pathol"},{"key":"527_CR71","volume-title":"Birt-Hogg-Dub\u00e9 syndrome. GeneReviews(\u00ae)","author":"EC Sattler","year":"1993","unstructured":"Sattler EC, Steinlein OK (1993) Birt-Hogg-Dub\u00e9 syndrome. GeneReviews(\u00ae). University of Washington, Seattle, Seattle (WA)"},{"key":"527_CR72","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.rmed.2014.11.008","volume":"109","author":"AA Dal Sasso","year":"2015","unstructured":"Dal Sasso AA, Bel\u00e9m LC, Zanetti G, Souza CA, Escuissato DL, Irion KL et al (2015) Birt-Hogg-Dub\u00e9 syndrome. State-of-the-art review with emphasis on pulmonary involvement. Respir Med 109:289\u2013296","journal-title":"Respir Med"},{"key":"527_CR73","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nrurol.2015.206","volume":"12","author":"LS Schmidt","year":"2015","unstructured":"Schmidt LS, Linehan WM (2015) Molecular genetics and clinical features of Birt-Hogg-Dub\u00e9 syndrome. Nat Rev Urol 12:558\u2013569","journal-title":"Nat Rev Urol"},{"key":"527_CR74","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12882-024-03775-9","volume":"25","author":"S Kijlertsuphasri","year":"2024","unstructured":"Kijlertsuphasri S, Petnak T, Moua T (2024) Diagnosis of renal tumors in Birt-Hogg-Dube syndrome: clinical presentation and risk factors in a single-center retrospective cohort. BMC Nephrol 25:329","journal-title":"BMC Nephrol"},{"key":"527_CR75","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10689-017-0008-8","volume":"17","author":"M Schneider","year":"2018","unstructured":"Schneider M, Dinkelborg K, Xiao X, Chan-Smutko G, Hruska K, Huang D et al (2018) Early onset renal cell carcinoma in an adolescent Girl with germline FLCN exon 5 deletion. Fam Cancer 17:135\u2013139","journal-title":"Fam Cancer"},{"key":"527_CR76","doi-asserted-by":"publisher","first-page":"1292378","DOI":"10.1080\/20018525.2017.1292378","volume":"4","author":"DK Jensen","year":"2017","unstructured":"Jensen DK, Villumsen A, Skytte A-B, Madsen MG, Sommerlund M, Bendstrup E (2017) Birt\u2013Hogg\u2013Dub\u00e9 syndrome: a case report and a review of the literature. Eur Clin Respir J 4:1292378","journal-title":"Eur Clin Respir J"},{"key":"527_CR77","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1097\/01.ju.0000154629.45832.30","volume":"173","author":"CP Pavlovich","year":"2005","unstructured":"Pavlovich CP, Grubb RL 3rd, Hurley K, Glenn GM, Toro J, Schmidt LS et al (2005) Evaluation and management of renal tumors in the Birt-Hogg-Dub\u00e9 syndrome. J Urol 173:1482\u20131486","journal-title":"J Urol"},{"key":"527_CR78","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","volume":"26","author":"CP Pavlovich","year":"2002","unstructured":"Pavlovich CP, Walther MM, Eyler RA, Hewitt SM, Zbar B, Linehan WM et al (2002) Renal tumors in the Birt-Hogg-Dub\u00e9 syndrome. Am J Surg Pathol 26:1542\u20131552","journal-title":"Am J Surg Pathol"},{"key":"527_CR79","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.eururo.2025.03.012","volume":"88","author":"S Gupta","year":"2025","unstructured":"Gupta S, Dasari S, Warren RR, Shen W, Urban RM, Stanton ML et al (2025) Renal neoplasia in Birt-Hogg-Dub\u00e9 syndrome: integrated histopathologic, bulk, and single-cell transcriptomic analysis. Eur Urol 88:263\u2013273","journal-title":"Eur Urol"},{"key":"527_CR80","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S1470-2045(09)70188-3","volume":"10","author":"FH Menko","year":"2009","unstructured":"Menko FH, van Steensel MAM, Giraud S, Friis-Hansen L, Richard S, Ungari S et al (2009) Birt-Hogg-Dub\u00e9 syndrome: diagnosis and management. Lancet Oncol 10:1199\u20131206","journal-title":"Lancet Oncol"},{"key":"527_CR81","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/j.1365-4632.2004.02095.x","volume":"44","author":"MJ Welsch","year":"2005","unstructured":"Welsch MJ, Krunic A, Medenica MM (2005) Birt-Hogg-Dub\u00e9 syndrome. Int J Dermatol 44:668\u2013673","journal-title":"Int J Dermatol"},{"key":"527_CR82","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10689-013-9657-4","volume":"12","author":"L Stamatakis","year":"2013","unstructured":"Stamatakis L, Metwalli AR, Middelton LA, Marston Linehan W (2013) Diagnosis and management of BHD-associated kidney cancer. Fam Cancer 12:397\u2013402","journal-title":"Fam Cancer"},{"key":"527_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-024-01671-2","author":"M Geilswijk","year":"2024","unstructured":"Geilswijk M, Genuardi M, Woodward ER, Nightingale K, Huber J, Madsen MG et al (2024) ERN GENTURIS clinical practice guidelines for the diagnosis, surveillance and management of people with Birt-Hogg-Dub\u00e9 syndrome. Eur J Hum Genet. https:\/\/doi.org\/10.1038\/s41431-024-01671-2","journal-title":"Eur J Hum Genet"},{"key":"527_CR84","first-page":"897","volume":"46","author":"Expert Consensus Group of the Exper","year":"2023","unstructured":"Expert Consensus Group of the Expert Consensus on the Diagnosis and Management of Birt-Hogg-Dub\u00e9 Syndrome, China Alliance for the Rare Lung Disease, Chinese Thoracic Society, Chinese Medical Association, Southern China Rare Lung Disease Committee of China Primary Health Care Foundation (2023) Expert consensus on the diagnosis and management of Birt-Hogg-Dub\u00e9 syndrome. Zhonghua Jie He He Hu Xi Za Zhi 46:897\u2013908","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"527_CR85","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13023-014-0163-z","volume":"9","author":"PR Benusiglio","year":"2014","unstructured":"Benusiglio PR, Giraud S, Deveaux S, M\u00e9jean A, Correas J-M, Joly D et al (2014) Renal cell tumour characteristics in patients with the Birt-Hogg-Dub\u00e9 cancer susceptibility syndrome: a retrospective, multicentre study. Orphanet J Rare Dis 9:163","journal-title":"Orphanet J Rare Dis"},{"key":"527_CR86","doi-asserted-by":"publisher","unstructured":"Jonasch E, Song Y, Freimark J (2022) Healthcare resource utilization costs among patients von Hippel-Lindau disease-associated renal cell carcinoma: retrospective administrative claims analysis. J Clin Oncol. https:\/\/doi.org\/10.1200\/jco.2022.40.6_suppl.305","DOI":"10.1200\/jco.2022.40.6_suppl.305"},{"key":"527_CR87","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/GIM.0b013e3182091a1d","volume":"13","author":"CRM Lammens","year":"2011","unstructured":"Lammens CRM, Aaronson NK, Hes FJ, Links TP, Zonnenberg B, Lenders JWM (2011) Compliance periodic surveillance Von- Hippel-Lindau disease. Genet Med 13:519\u2013527","journal-title":"Genet Med"},{"key":"527_CR88","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/jmedgenet-2011-100562","volume":"49","author":"A Wilding","year":"2012","unstructured":"Wilding A, Ingham SL, Lalloo F, Clancy T, Huson SM, Moran A et al (2012) Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet 49:264\u2013269","journal-title":"J Med Genet"},{"key":"527_CR89","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/jmedgenet-2016-104058","volume":"54","author":"MLM Binderup","year":"2017","unstructured":"Binderup MLM, Jensen AM, Budtz-J\u00f8rgensen E, Bisgaard ML (2017) Survival and causes of death in patients with von Hippel-Lindau disease. J Med Genet 54:11\u201318","journal-title":"J Med Genet"},{"key":"527_CR90","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0022-5347(17)35015-2","volume":"151","author":"B Zbar","year":"1994","unstructured":"Zbar B, Tory K, Merino M, Schmidt L, Glenn G, Choyke P et al (1994) Hereditary papillary renal cell carcinoma. J Urol 151:561\u2013566","journal-title":"J Urol"},{"key":"527_CR91","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0022-5347(01)67601-8","volume":"153","author":"B Zbar","year":"1995","unstructured":"Zbar B, Glenn G, Lubensky I, Choyke P, Walther MM, Magnusson G et al (1995) Hereditary papillary renal cell carcinoma: clinical studies in 10 families. J Urol 153:907\u2013912","journal-title":"J Urol"},{"key":"527_CR92","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1148\/radiol.2261011296","volume":"226","author":"PL Choyke","year":"2003","unstructured":"Choyke PL, Glenn GM, Walther MM, Zbar B, Linehan WM (2003) Hereditary renal cancers. Radiol 226:33\u201346","journal-title":"Radiol"},{"key":"527_CR93","doi-asserted-by":"publisher","first-page":"e0212952","DOI":"10.1371\/journal.pone.0212952","volume":"14","author":"PC Johannesma","year":"2019","unstructured":"Johannesma PC, van de Beek I, van der Wel TJWT, Reinhard R, Rozendaal L, Starink TM et al (2019) Renal imaging in 199 Dutch patients with Birt-Hogg-Dub\u00e9 syndrome: screening compliance and outcome. PLoS ONE 14:e0212952","journal-title":"PLoS ONE"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00527-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-025-00527-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00527-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T18:01:44Z","timestamp":1768068104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-025-00527-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1007\/s10689-025-00527-y","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"28 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"10"}}